Development and application of an indirect enzyme-linked immunosorbent assay using recombinant truncated Cap protein for the diagnosis of porcine circovirus-like virus P1 by Li-bin Wen et al.
METHODOLOGY ARTICLE Open Access
Development and application of an indirect
enzyme-linked immunosorbent assay using
recombinant truncated Cap protein for the
diagnosis of porcine circovirus-like virus P1
Li-bin Wen1,2,3*†, Shi-fu Wen1,2,3† and Kong-wang He1,2,3
Abstract
Background: Porcine circovirus-like virus P1 is a newly discovered virus. To date, there has been no specific
serological assay for use in the diagnosis of P1 infection.
Results: Because P1 has high homology to porcine circovirus type 2 (PCV2) at the nucleotide level, the C-terminal
portion of the capsid protein (amino acids 73–114), a discriminative antigen, was expressed in a prokaryotic
expression system. The recombinant product (rctCap), composed of three identical repeated domains, was shown
to be strongly immunoreactive to P1-specific serum. This assay was validated by comparison with an indirect
immunofluorescence assay (IFA). The diagnostic sensitivity and specificity of the rctCap enzyme-linked
immunosorbent assay (ELISA) developed in this study are 93.6 % and 98.3 %, respectively, compared with the
results from IFAs on 450 sera samples from pigs.
Conclusions: The indirect ELISA that we developed with rctCap, the recombinant capsid fragment containing the
217–342 nt repeat domain, was sensitive, specific, and suitable for the large-scale detection of P1 infections in
swine.
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Background
Porcine circovirus (PCV) is a nonenveloped, single-
stranded, DNA virus with a circular genome of approxi-
mately 1.7 kb, belonging to the family Circoviridae. Por-
cine circovirus type 1 (PCV1) was first isolated as a non-
pathogenic contaminant virus in a porcine kidney cell
line [1], whereas porcine circovirus type 2 (PCV2) is rec-
ognized as a causative agent of postweaning multisyste-
mic wasting syndrome (PMWS) [2], a multifactorial
swine disease first identified in Canada in 1991 [3].
PCV2 has since been reported in most pig-producing
countries worldwide, including China [4–6]. The PCV2
genome contains three major open reading frames
(ORFs): ORF1, ORF2, and ORF3 [7–9]. ORF1 encodes
the 35.7-kDa Rep proteins, which are essential for viral
DNA replication [10]; ORF2 encodes the 30-kDa struc-
tural capsid protein involved in the host immune re-
sponse [11]; and the ORF3 protein is involved in PCV2-
induced host cell apoptosis [12].
Porcine circovirus-like virus P1 was recently identified
and has the smallest genome of all DNA viruses (648
nucleotides), which is highly homologous to that of
PCV2. Like the PCVs, P1 has a single-stranded circular
DNA genome. P1 is thought to be a recombinant virus
formed between PCV2 and another virus [13], and it
similarly contains three major ORFs: ORF1, ORF2, and
ORF3. Recently, we reported that ORF1 of P1 encodes a
major structural protein of approximately 12.5 kDa. This
protein reacts strongly with serum from P1-infected
swine, suggesting its possible utility in diagnostic assays
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[14]. A comparison of the deduced N-terminal amino
acid sequence of P1 ORF1 revealed that it has a high
homology with the N-terminal domain of PCV2 ORF2.
However, they only share a low amino acid sequence
homology in the C-terminal region because there has
been a frameshift in the P1 ORF1.
Epidemiological studies have confirmed that the P1
virus is endemic on pig farms in China [15]. In vivo
studies have shown that P1 infects pigs and the infected
animals show the clinical signs of PMWS [16].
To determine the prevalence of P1 infection and
to clarify how PMWS develops, specific tools for
antibody detection are essential. Testing for P1 anti-
bodies in sera is currently performed with indirect
immunofluorescence assays (IFAs) or immunoperoxi-
dase monolayer assays (IPMAs) [16]. However, these
assays are very time-consuming, whereas enzyme-
linked immunosorbent assays (ELISAs) can be auto-
mated and are more convenient. Notably, two anti-
genic epitopes of the P1 capsid (Cap) protein have
been identified at amino acid residues 6–18 and 80–
92. A peptide antibody derived from the immunore-
levant 6–18 epitope was used in our previous inves-
tigations [17]. However, the resulting test was not
specific for P1 because there is a slight amount of
antigenic cross-reactivity between PCV2 and P1. A
2014 report demonstrated that a peptide antibody
test using the 80–92 epitope was highly specific for
P1. Therefore, we used this epitope to establish
methods for the specific serological detection of P1
[17]. A recombinant C-terminally truncated capsid
protein (rctCap) of P1, expressed in an Escherichia
coli system, was used as an antigen to develop an in-
direct ELISA.
The objectives of the present study were to establish
and validate a diagnostic indirect ELISA for the sero-
logical detection of anti–P1 serum antibodies.
Methods
Ethics statement
This study was approved by the Committee on the Eth-
ics of Animal Experiments of the Institute of Veterinary
Medicine, Jiangsu Academy of Agricultural Sciences
(JAAS no 20100604) (Nanjing, China).
Expression, purification, and identification of the rctCap
protein
To construct a plasmid expressing rctCap, genomic
DNA was obtained from P1-infected porcine kidney epi-
thelial (PK15) cells and used as the template for poly-
merase chain reaction (PCR). To obtain the target gene,
ORF1 without the N-terminal 216-nucleotides (nt), three
pairs of primers (Table 1) were designed according to
the published genome sequence of P1 strain JSNJ (Gen-
Bank: KJ612072).
The PCR product generated using the A1 and A2
primer pair was doubly digested with NcoI and EcoRI
and cloned into the prokaryotic expression vector
pET-28a (+) (Invitrogen, CA, USA). The resulting re-
combinant expression plasmid, pET28a-mono-ORF1
was ligated to the PCR product generated with the
B1 and B2 primer pair and doubly digested with
EcoRI and SacI. The PCR product generated using
the C1 and C2 primer pair was then digested with
the SacI and HindIII endonucleases and transferred
into the above construct, resulting in the recombinant
expression plasmid, pET28a-bi-ORF1. The pET28a-tri-
ORF1 plasmid was then constructed similarly and
used to transform competent E. coli DH5α cells
(Fig. 1). Clones containing the recombinant plasmid
were identified with restriction enzyme digestion and
DNA sequencing (GenScript Corporation, China).
The rctCap plasmid has three tandem repeats, each
encoding 42 amino acids. The three central repeats are
identical except for a few linker amino acids.
To express the cloned gene, competent E. coli BL21-
(DE3) cells (TransGen Biotech, China) were transformed
with pET28a-tri-ORF1. Alternately, these cells were
transformed with plasmid pET-28a (+) as a control.
Single-positive clones of the transformed cells were
grown in Luria-Bertani medium containing 80 μg/ml
kanamycin at 37 °C (with shaking) to an optical density
at 600 nm (OD600) of about 0.4–0.6. Protein expressin
was induced in these cells by the addition of isopropyl
Table 1 Sequences of primers used for the PCRs
Primers Sequences (5′-3′) Underlined restriction site





C2 CGAAGCTTATTAGCCAAAGCTGATTCCTTTTGTT Hind III
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β-D-1-thiogalactoside (IPTG) to a final concentration of
1 mM for 6–8 h at 37 °C. The bacteria were pelleted and
resuspended in phosphate-buffered saline (PBS), and
then lysed with sonication on ice. The sonicated cells
were centrifuged at 10,000 × g for 30 min at 4 °C and
the precipitate was resuspended and purified by Ni2
+-NTA agarose (Qiagen, Germany), according to the
manufacturer’s instructions. The eluates containing the
rctCap protein were pooled and dialyzed against 0.01 M
PBS (pH 7.2). The purified proteins were analyzed with
sodium dodecyl sulfate–polyacrylamide gel electrophor-
esis (SDS-PAGE) and transferred electrophoretically to a
nitrocellulose membrane. The membrane was blocked
with blocking buffer (Tris-buffered saline containing
0.1 % Tween-20 and 2 % skim milk powder) overnight at
4 °C and then incubated with rabbit anti-P1 antibody
(diluted 1:200) raised against the synthetic peptide
CSPNPSPTTPVTSH. Horseradish peroxidase (HRP)-
conjugated goat anti-rabbit IgG antibody (1:3000) (Bos-
ter Biological Technology, Wuhan, China) was used as
the secondary antibody. Immunoreactivity was visualized
with diaminobenzidine (Boster Biological Technology).
The concentration of the purified rctCap protein was
determined with the Bradford method using bovine
serum albumin (BSA, Sigma-Aldrich, St. Louis, MO,
USA) as the standard, and the purified rctCap protein
was stored at −70 °C until use in later assays.
ELISA procedure
High-binding 96-well microtiter plates (Greiner BioOne,
USA) were coated with 100 μl of rctCap protein in
0.05 M bicarbonate/carbonate buffer (pH 9.6) overnight
at 4 °C. After three washes in PBS (pH 7.4) containing
0.05 % Tween 20 (PBS-T), the plates were blocked with
1 % BSA for 1 h at 37 °C. Serum samples were diluted in
PBS (pH 7.4) containing 5 % dry milk, 100 μl of the di-
luted samples were added to the wells, and the plates
were incubated for 1.5 h at 37 °C. The plates were then
washed five times with PBS-T and incubated for 45 min
at 37 °C with 100 μl of diluted HRP-conjugated goat
anti-swine IgG antibody (KPL, Gaithersburg, MD). The
plates were then washed four times, and the colorimetric
reaction was developed with 50 μl of Tetramethylbenzi-
dine Liquid Substrate (Sigma-Aldrich) for 10 min at 37 °
C. The color reaction was stopped by the addition of
50 μl of 1 M H2SO4, and the OD450 was measured with
a microplate reader (Bio-Tek Instruments, USA).
Based on the procedure described above, the optimal
antigen concentration and serum dilution were deter-
mined with a checkerboard serum dilution analysis. In
brief, the rctCap protein was serially diluted 2-fold from
5.24 μg/ml to 0.33 μg/ml. Additionally, P1-positive swine
sera and P1 seronegative control swine sera were also
subjected to a similar serial 2-fold dilution from 1:25
−1:800 for use in the optimization of the rctCap ELISA.
After the optimal antigen and antiserum dilutions were
established, the HRP-labeled goat anti-swine IgG anti-
body was added to the plate at dilutions of 1:5000,
1:10,000, 1:20,000, and 1:40,000 to determine the opti-
mal detection antibody dilution for this ELISA. The con-
ditions that gave the highest positive control OD450/
negative control OD450 (P/N) ratio and had an OD450
value close to 1.0 for positive serum were considered to
be the optimal working conditions.
Determination of the negative–positive cut-off
Nine hundred swine serum samples were collected se-
quentially from P1-free pigs that tested negative both for
P1 antibodies via IFA and for P1 nucleic acids via PCR as-
says. These samples were used to set the negative–positive
cut-off value for the rctCap ELISA. The mean S/P ratio
(x) and standard deviation (SD) were calculated, and the
cut-off value was calculated as x + (3 × SD).
Evaluation of assay performance
To evalute the negative–positive cut-off value for this
assay, 450 serum samples from farm pigs were tested in
duplicate with the newly developed rctCap ELISA. The
diagnostic accuracy of this ELISA was determined by
calculating the diagnostic sensitivity and specificity of
the test. IFA was used as the reference method to clas-
sify the samples as positive or negative. The sensitivity
and specificity of the rctCap ELISA were determined as
follows: sensitivity = (TP/[TP + FN]) × 100, and specifi-
city = (TN/[TN + FP]) × 100, where TP, FN, TN and FP
indicate the true-positive, false-negative, true-negative,
and false-positive, respectively.
To detect the specificity of the rctCap ELISA, sero-
positive sera for PCV2, classical swine fever virus
Fig. 1 Construction of the rctCap expression plasmid. A schematic
diagram showing the construction of the rctCap expression plasmid
used in this study. The fragments of identical sequence are marked
in red
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(CSFV), porcine parvovirus (PPV), porcine pseudorabies
virus (PRV), or porcine reproductive and respiratory
syndrome virus (PRRSV) were tested with the rctCap
ELISA. Each sample was tested in triplicate, and the S/P
ratios were calculated.
Determination of assay reproducibility
To determine the reproducibility of the rctCap ELISA,
six serum samples from farm pigs (three IFA-postitve
samples and three IFA-negative samples) were selected
for use in the reproducibility experiments. We ran four
replicates of each serum sample on the same plate to as-
sess the intra-assay (within-plate) reproducibility, and we
ran five replicates of each sample on different plates to
assess the inter-assay (between-run) reproducibility.
The results were used to calculate the mean S/P ratios
and coefficients of variation (CV).
IFA
Confluent PK15 cell monolayers, either untransfected
or transfected with an infectious molecular clone of
the P1 virus, in 96-well plates (Costar, Corning, NY,
USA) were fixed in methanol-acetone for 15 min at
−20 °C, and the plate was then washed three times
with PBS (pH 7.2). Serum samples (50 μl) diluted
1:20 in PBST were added to the plates and incubated
for 1 h at 37 °C. After three washes with PBST,
fluorescein-conjugated anti-swine IgG antibody
(KPL), diluted 1:100, was added and the samples
were incubated for 30 min at 37 °C. Fluorescence
was observed with an inverted fluorescence micro-
scope (Olympus, Japan).
Serum samples
A serological study was performed to estimate the
seroprevalence of P1 in the swine population. Serum
samples (n = 1135) were collected randomly from 11
herds with or without PMWS in the Jiangsu, Anhui,
Shandong, and Zhejiang Provinces and Shanghai Mu-
nicipality, China in 2008–2011. The origins of the
serum samples were as follows: 86 and 70 serum
samples were from farm A and farm B in Jiangsu
Province, respectively; 72, 86, and 54 serum samples
were from farm C, farm D, and farm E in Anhui
Province, respectively; 42 and 106 serum samples
were from farm F, and farm G in Shandong Province,
respectively; 90 serum samples were from farm H in
Shanghai Municipality; and 55, 69, and 405 serum
samples were from farm I, farm J, and farm K in
Zhejiang Province, respectively. The 405 serum sam-
ples from farm K in Zhejiang Province were obtained
from different animal growth stages: suckling piglets
(0–5 weeks, 140 sera), nursing pigs (8–13 weeks, 145
sera), fattening pigs (18–19 weeks, 60 sera), sows (45
sera), and breeding boar (15 sera).
Results
Cloning, expression and purification of the rctCap protein
The truncated ORF1 was amplified with PCR and used
with the appropriate primers to construct the recombin-
ant truncated ORF1 fragment, which is composed of
three repeated identical domains. The result was cloned
into the pET-28a (+) vector, from which recombinant
proteins were expressed as histidine (His) fusion pro-
teins. After IPTG induction, the recombinant E. coli car-
rying the pET-28a-tri-ORF1 cassette expressed a 14.7-
kDa protein, which corresponded to the expected size of
the rctCap protein (containing an N-terminal peptide of
six histidines). The recombinant protein was expressed
as inclusion bodies in E. coli, and its size was confirmed
with SDS-PAGE. E.coli carrying the recombinant plas-
mid were lysed with lysozyme (final concentration,
1 mg/ml) and sonication. The rctCap protein was puri-
fied from the lysate by using affinity chromatography.
Most of the rctCap protein was eluted from a Ni2+-NTA
affinity column. The purified protein was separated with
SDS-PAGE and blotted onto a nitrocellulose membrane
for immunodetection. The SDS-PAGE analysis of the
eluted fractions revealed that the protein was purified as
Fig. 2 Identification of the rctCap protein with SDS-PAGE and western
blotting. M: protein molecular weight marker; 1: IPTG-induced cell lysate;
2: rctCap protein purified with a Ni2+-NTA affinity chromatography
column; 3: the purified rctCap protein reacted strongly with rabbit
anti-P1 polyclonal antibody detected with HRP- conjugated goat
anti-rabbit antibody as the secondary antibody
Wen et al. BMC Veterinary Research  (2016) 12:12 Page 4 of 7
a single 15-kDa band. The reactivity of the rctCap pro-
tein to rabbit anti-P1 serum was observed with a west-
ern blotting assay (Fig. 2). These results confirm that
this antigen can be used to detect specific antibodies di-
rected against P1.
Optimization of the rctCap ELISA
We used checkboard ELISAs to determine the optimal
antigen concentration and the serum sample dilution,
which were set at 2.62 μg/ml and 1:100, respectively,
based on the criteria that under these conditions the
OD450 value for positive serum was close to 1.0 and the
P/N value was highest. After these conditions were met,
other factors in the rctCap ELISA were optimized. We
found that 1 % BSA was the best blocking solution for
this assay., giving the highest P/N value, compared with
the other tested blocking solutions The optimal dilution
of the conjugate was 1:5000. When the optimal exposure
time for the serum samples or detection antibody was
investigated, incubation for 90 min or 45 min, respect-
ively, was shown to be best.
Reproducibility of the rctCap ELISA
The intra-assay and inter-assay reproducibility of the
rctCap ELISA were determined by comparing the S/P
ratios for each farm pig serum sample tested in tripli-
cate. The intra-assay CVs of three serum samples that
had been determined as P1 seropositive by IFA (IFA-
positive) in the rctCap ELISA ranged from 1.5–3.3 %.
The inter-assay CVs for IFA-positive serum samples in
the rctCap ELISA ranged from 2.91–7.61 % (Table 2).
The rctCap ELISA also showed good repeatability with
three pig sera that had been determined as P1 seronega-
tive by IFA (IFA-negative), as indicated by the low vari-
ability among the three replicates of identical samples.
These data show that this assay is repeatable, yielding
acceptably low levels of variation.
Determination of the negative–positive cut-off
To set a negative–positive cut-off value for the rctCap
ELISA, 900 presumed P1 seronegative farm swine sera
collected from normal uninfected pigs were examined.
The mean ± SD OD450 value for the normal pig sera in
the rctCap ELISA was 0.21008 ± 0.04484, which gave a
negative–positive cut-off S/P value of approximately
0.345 (mean + 3SD) for this assay. Therefore, serum
samples with an OD450 > 0.345 in this assay were
regarded as seropositive for P1.
Specificity of the rctCap ELISA
The specificity of the rctCap ELISA was determined by
testing the reactivity of 10 samples each of PPV, CSFV,
PRV, PRRSV, or PCV2-positive sera, which came from
the commercial ELISA kit. The results show that the
mean OD450 values for the sera, described above were
0.193, 0.131, 0.185, 0.178, and 0.206, respectively. There-
fore, based on our defined negative–positive cut-off
value of OD450 > 0.345, none of these antisera was de-
tected as P1 seropositive by the rctCap ELISA. These
findings confirm that the rctCap antigen is specific for
antibodies directed against P1.
Validation of the rctCap ELISA
Of the 1135 swine serum samples described above, 450
randomly selected samples were assessed with both the
rctCap ELISA and IFA. Of these, IFA found 162 samples
as P1 seropositive and 288 samples as P1 seronegative,
while evaluation with the rctCap ELISA at a cutoff value
of 0.345 found 156 samples as P1 seropositive and 294
samples as P1 seronegative. When the samples were
judged by both methods, 151 were considered P1 sero-
positive and 283 were considered P1 seronegative. Com-
paratively, five samples assessed as P1 seropositive by
the rctCap ELISA were assessed as P1 seronegative by
the IFA, and 11 samples determined as P1 seronegative
by the rctCap ELISA were assessed as P1 seropositive by
the IFA (Table 3). The sensitivity and specificity of the
rctCap ELISA were 93.6 % and 98.3 %, respectively,
based on the assumption that the IFA, considered the
gold standard for P1 antibody detection, was 100 % ac-
curate. The rate of accordbetween these two methods
was 96.4 %.
Results for farm pig serum samples assessed by the
rctCap ELISA
The results for the 1135 farm pig serum samples tested
with the rntCAP ELISA are presented in Table 4. Of
these, 352 samples were positive and 783 samples wereTable 2 Repeatability of the rctCap ELISA for IFA-positive serum
samples of farm pig sera
Repeatability Intra-assay Inter-assay
1 1.162 1.040 1.233 0.878 1.113 1.134
2 1.135 1.079 1.191 0.913 1.220 1.088
3 1.121 1.066 1.164 0.934 1.231 1.261
4 1.137 1.008 1.252 0.886 1.019 1.146
5 - - - 0.872 1.178 1.053
CV 1.50 % 3.00 % 3.30 % 2.91 % 7 .61 % 6.95 %






Positive 151 11 162
Negative 5 283 288
Total 156 294 450
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negative for anti-P1 antibodies. The seroprevalence of
P1 in farm K in Zhejiang Province was 48.6 % for suck-
ling piglets, 34.5 % for nursing pigs, 18.3 % for fattening
pigs, 53.3 % for sows, and 20 % for breeding boars
(Table 5).
Discussion
The increasing incidence of PMWS on pig farms has be-
come a real threat to the global swine industry. Because
P1 is associated with PMWS [16], detecting P1 in pig
herds is essential for the control of this syndrome.
Therefore P1-specific diagnostic tools are required to
clarify the course of infection. To date, only PCR, IFA,
and IPMA assay are used to detect P1 infection.
IFA is considered to be a sensitive method for detect-
ing P1, but it requires virus-infected cells as well as ex-
perienced technicians to examine the stained plates, and
it is laborious and time-consuming. Therefore, IFA is
not suitable for large-scale surveys. The purpose of this
study was to develop an indirect ELISA to detect anti-
bodies specific for P1.
The N-terminal region of Cap contains one potential
epitope shared by PCV2 and P1. Therefore, to avoid
complications from antigenic cross-reactivity, we did not
use the full-length Cap protein in this assay. The C-
terminal 42 amino acids of Cap are unique to P1 and
can be used to differentiate between antibodies directed
against PCV2 and those directed against P1. However,
because the conserved C-terminal region is very small,
we constructed a plasmid containing three tandem re-
peats, each encoding the same 42 amino acids. Each 42-
amino acid repeat was separated by 6 nt of a restriction
enzyme recognition site, which created a two amino-acid
linker between repeats. The plasmid was also con-
structed in frame with an N-terminal peptide of six
histidines, which allowed the expressed capsid protein to
be purified easily with chromatography. A strong specific
signal was observed via western blotting, confirming that
the truncated protein did not destroy the C-terminal
epitope.
We compared the newly developed indirect ELISA for
detecting P1-specific antibodies with an IFA. The data
from the rctCap ELISA agreed quite well with the data
from the IFA, with a relative sensitivity of 93.6 % and a
specificity of 98.3 %.
There is high homology between the amino acid se-
quences of ORF2 of PCV2 and ORF1 of P1, especially in
the N-terminal regions. Therefore, to determine the use-
fulness of the rctCap ELISA for P1, we had to evaluate
its specificity against PCV2. Our results confirm that the
rctCap ELISA does not react with antibodies directed
against PCV2. Our data also demonstrate the specificity
of this assay, which does not detect antibodies directed
against PPV, CSFV, PRV, or PRRSV.
Epidemiological studies of P1 infections conducted on
11 farms in China showed that all of the herds were P1
seropositive, except for one, irrespective of the presence
or absence of clinical signs of PMWS. A high P1 sero-
prevalence was observed in suckling piglets and sows
(48.6 % and 53.3 %, respectively).
Conclusions
The rctCap ELISA described in this study can be
used for the detection of antibodies directed against
P1, and this assay is highly sensitive, specific, and
widely applicable to screening large numbers of serum
samples. This report is the first to demonstrate differ-
ent P1 serological profiles of pigs at different stages
in herds with or without clinical signs of PMWS.
However, further serological surveys are required to
determine the dynamics of P1 infection in herds and
the relationship of P1 to PMWS.
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Table 4 Prevalence of antibodies to P1 by ELISA in swine serum samples obtained from Jiangsu, Anhui, Shandong, Shanghai and
Zhejiang
Farms Jiangsu Anhui Shandong Shanghai Zhejiang
A B C D E F G H I J K
No. of sera tested 86 70 72 86 54 42 106 90 55 69 405
No. of sera positive 3 51 14 7 19 35 32 13 0 22 156
% sera positive 3.5 72.9 19.4 8.1 35.2 83.3 30.2 14.4 0 31.9 38.5
Table 5 Anti-P1 antibodies in different categories of pigs from











140 145 60 45 15
No. of sera
positive
68 50 11 24 3
% sera positive 48.6 34.5 18.3 53.3 20
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